Summary

Report Scope
The report provides an overview of the global market for cell and gene therapy tools and reagents. It includes global revenue ($ millions) for the base year 2024, estimated data for 2025, and forecast data from 2026 through 2030. In this report, the market is segmented based on product type, application and end user. By product type, the market is segmented into vectors, GMP proteins, GMP antibodies, GMP small molecules, bioreactors, multiplex immunoassays, immunoassays, leukapheresis, cell separation, cell expansion, cytokine release syndrome (CRS) monitoring, cryopreservation and media. The application segment covered cancer, rare diseases and other diseases. By end user, the market is divided into pharmaceutical and biotechnology companies, academic research institutes, and clinical laboratories. The regions covered in this study are North America, Europe, Asia-Pacific and rest of the World (RoW) (which includes the Middle East and Africa and South America), with analysis of the markets in the U.S., Canada, Mexico, Germany, the U.K., Italy, France, Spain, the rest of Europe, China, Japan, India, South Korea and the rest of Asia-Pacific. The report covers the trends and challenges that affect the market. It includes an analysis of the competitive landscape, with the ranking of leading companies and their market shares. The report also has a dedicated section of company profiles that covers details of leading companies. It analyzes companiesf environmental, social and corporate governance (ESG) initiatives.

Report Includes
- 77 data tables and 55 additional tables
- An overview of the global market for cell and gene therapy tools and reagents
- In-depth analysis of global market trends, featuring historical revenue data for 2022-2025. This analysis includes projections of compound annual growth rates (CAGRs) through 2030
- Evaluation of the current market size and revenue growth prospects specific to the cell and gene therapy tools and reagents market, accompanied by a market share analysis by type, application, end user, and region
- Analysis of current and future demand in the cell and gene therapy tools and reagents market, along with a detailed analysis of the competitive environment, market regulations and reimbursement practices
- Discussion of the prevalence of infectious disease, metabolic disorders and chronic ailments, along with the recent technological advances, competitive landscape, and the industry value chain
- Analysis of drivers, challenges, and opportunities affecting market growth
- Coverage of evolving technologies, the current and future market potential, R&D activities, growth strategies, new product pipeline, regulatory framework and reimbursement scenarios, and ESG trends of the market
- Market share analysis of the key market participants in the industry, along with their research priorities, product portfolios, global rankings and company competitive landscape
- Profiles of major companies within the industry, including Thermo Fisher Scientific Inc., Cytiva (Danaher Corp.), Merck KGaA, Miltenyi Biotec, and Sartorius AG

ページTOPに戻る

Table of Contents

Table of Contents

Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary
Overview
Current Market Scenario
Segmental Analysis
Regional Market Insights
Emerging Technologies
Conclusion
Chapter 2 Market Overview
Cell and Gene Therapy Overview
Cell Therapy
Gene Therapy
Types of Cell and Gene Therapy
Gene Therapy
Cell Therapy
Common Equipment Used
Approved Cell and Gene Therapy Products
Macroeconomic Factors Analysis
Demographic Factors
Geopolitical Factors
Impact of U.S. Tariffs
Porter's Five Forces Analysis
Chapter 3 Market Dynamics
Market Dynamics
Market Drivers
Increasing Investments in CGT Research
Expanding Clinical and Commercial CGT Products
Rising Demand for Precision Medicine
Capacity Expansions for Clinical and Commercial Manufacturing
Growing Number of Strategic Initiatives
Rising Aging Population and the Increasing Prevalence of Chronic Diseases
Market Restraints/Challenges
Complex Manufacturing and Supply Chain
High Cost of Development
Lack of Skilled Workforce
Regulatory Hurdles
Market Opportunities
Rising Demand for CGTs in Emerging Countries
Growing Demand for Off-the-Shelf Products
Chapter 4 Regulatory Landscape
Overview
U.S.
Cell Therapy Regulations
Gene Therapy Regulations
Viral and Non-Viral Vectors
Media
GMP Proteins and Antibodies
Leukapheresis
Europe
Asia-Pacific
Chapter 5 Emerging Technologies and Developments
Key Takeaways
Closed and Automated Systems
Single-Use Technologies and Miniaturization
Chapter 6 Market Segmentation Analysis
Segmentation Breakdown
Market Analysis by Product Type
Key Takeaways
Immunoassays
Bioreactors
Leukapheresis
GMP Antibodies
Multiplex Immunoassays
Vectors
Cell Separation
Cryopreservation
Cell Expansion
Media
GMP Proteins
GMP Small Molecules
CRS Monitoring
Market Analysis by Application
Key Takeaways
Cancer
Rare Diseases
Other Diseases
Market Analysis by End User
Key Takeaways
Pharmaceutical and Biotechnology Companies
Academic and Research Institutes
Clinical Laboratories
Geographic Breakdown
Market Analysis by Region
Key Takeaways
North America
Europe
Asia-Pacific
Rest of the World
Chapter 7 Competitive Intelligence
Key Takeaways
Competitive Analysis
Strategic Initiatives
Agreements, Collaborations and Partnerships
Acquisitions
Investments and Expansions
Chapter 8 Sustainability in Global Market for Cell and Gene Therapy Tools and Reagents: An ESG Perspective
Introduction to ESG
Sustainability Trends and Company Initiatives
Environmental Factors
Social Factors
Governance Factors
Social and Governance Initiatives
Concluding Remarks
Chapter 9 Appendix
Research Methodology
Sources
Abbreviations
Company Profiles
ABCAM LTD.
ADVERUM BIOTECHNOLOGIES INC.
AKRON BIOTECH
BIO-RAD LABORATORIES INC.
BIO-TECHNE
CYTIVA
FUJIFILM IRVINE SCIENTIFIC (FUJIFILM BIOSCIENCES)
MERCK KGAA
MILTENYI BIOTEC
PROTEINTECH GROUP INC.
QIAGEN
REVVITY
SARTORIUS AG
STEMCELL TECHNOLOGIES
THERMO FISHER SCIENTIFIC INC.
Emerging Startups/Market Disruptors

ページTOPに戻る

List of Tables/Graphs

List of Tables

Summary Table : Global Market for Cell and Gene Therapy Tools and Reagents, by Region, Through 2030
Table 1 : Approved Cell and Gene Therapy Products, as of October 2025
Table 2 : Incidence and Mortality Rates of Cancer Across Regions, 2022
Table 3 : Regulations for Advanced Therapies in the Asia-Pacific Region, 2025
Table 4 : Global Market for Cell and Gene Therapy Tools and Reagents, by Product Type, Through 2030
Table 5 : Global Market for Cell and Gene Therapy Tools and Reagents for Immunoassays, by Region, Through 2030
Table 6 : Global Market for Cell and Gene Therapy Tools and Reagents for Bioreactors, by Region, Through 2030
Table 7 : Global Market for Cell and Gene Therapy Tools and Reagents for Leukapheresis, by Region, Through 2030
Table 8 : Global Market for Cell and Gene Therapy Tools and Reagents for GMP Antibodies, by Region, Through 2030
Table 9 : Global Market for Cell and Gene Therapy Tools and Reagents for Multiplex Immunoassays, by Region, Through 2030
Table 10 : Global Market for Cell and Gene Therapy Tools and Reagents for Vectors, by Region, Through 2030
Table 11 : Global Market for Cell and Gene Therapy Tools and Reagents for Cell Separation, by Region, Through 2030
Table 12 : Global Market for Cell and Gene Therapy Tools and Reagents for Cryopreservation, by Region, Through 2030
Table 13 : Global Market for Cell and Gene Therapy Tools and Reagents for Cell Expansion, by Region, Through 2030
Table 14 : Global Market for Cell and Gene Therapy Tools and Reagents for Media, by Region, Through 2030
Table 15 : Global Market for Cell and Gene Therapy Tools and Reagents for GMP Proteins, by Region, Through 2030
Table 16 : Global Market for Cell and Gene Therapy Tools and Reagents for GMP Small Molecules, by Region, Through 2030
Table 17 : Global Market for Cell and Gene Therapy Tools and Reagents for CRS Monitoring, by Region, Through 2030
Table 18 : Global Market for Cell and Gene Therapy Tools and Reagents, by Application, Through 2030
Table 19 : Global Market for Cell and Gene Therapy Tools and Reagents for Cancer, by Region, Through 2030
Table 20 : Global Market for Cell and Gene Therapy Tools and Reagents for Rare Diseases, by Region, Through 2030
Table 21 : Global Market for Cell and Gene Therapy Tools and Reagents for Other Diseases, by Region, Through 2030
Table 22 : Global Market for Cell and Gene Therapy Tools and Reagents, by End User, Through 2030
Table 23 : Global Market for Cell and Gene Therapy Tools and Reagents for Pharmaceutical and Biotechnology Companies, by Region, Through 2030
Table 24 : Global Market for Cell and Gene Therapy Tools and Reagents for Academic and Research Institutes, by Region, Through 2030
Table 25 : Global Market for Cell and Gene Therapy Tools and Reagents for Clinical Laboratories, by Region, Through 2030
Table 26 : Global Market for Cell and Gene Therapy Tools and Reagents, by Region, Through 2030
Table 27 : North American Market for Cell and Gene Therapy Tools and Reagents, by Product Type, Through 2030
Table 28 : North American Market for Cell and Gene Therapy Tools and Reagents, by Application, Through 2030
Table 29 : North American Market for Cell and Gene Therapy Tools and Reagents, by End User, Through 2030
Table 30 : North American Market for Cell and Gene Therapy Tools and Reagents, by Country, Through 2030
Table 31 : U.S. Market for Cell and Gene Therapy Tools and Reagents, by Product Type, Through 2030
Table 32 : U.S. Market for Cell and Gene Therapy Tools and Reagents, by Application, Through 2030
Table 33 : Canadian Market for Cell and Gene Therapy Tools and Reagents, by Product Type, Through 2030
Table 34 : Canadian Market for Cell and Gene Therapy Tools and Reagents, by Application, Through 2030
Table 35 : Mexican Market for Cell and Gene Therapy Tools and Reagents, by Product Type, Through 2030
Table 36 : Mexican Market for Cell and Gene Therapy Tools and Reagents, by Application, Through 2030
Table 37 : European Market for Cell and Gene Therapy Tools and Reagents, by Product Type, Through 2030
Table 38 : European Market for Cell and Gene Therapy Tools and Reagents, by Application, Through 2030
Table 39 : European Market for Cell and Gene Therapy Tools and Reagents, by End User, Through 2030
Table 40 : European Market for Cell and Gene Therapy Tools and Reagents, by Country, Through 2030
Table 41 : German Market for Cell and Gene Therapy Tools and Reagents, by Product Type, Through 2030
Table 42 : German Market for Cell and Gene Therapy Tools and Reagents, by Application, Through 2030
Table 43 : U.K. Market for Cell and Gene Therapy Tools and Reagents, by Product Type, Through 2030
Table 44 : U.K. Market for Cell and Gene Therapy Tools and Reagents, by Application, Through 2030
Table 45 : French Market for Cell and Gene Therapy Tools and Reagents, by Product Type, Through 2030
Table 46 : French Market for Cell and Gene Therapy Tools and Reagents, by Application, Through 2030
Table 47 : Spanish Market for Cell and Gene Therapy Tools and Reagents, by Product Type, Through 2030
Table 48 : Spanish Market for Cell and Gene Therapy Tools and Reagents, by Application, Through 2030
Table 49 : Italian Market for Cell and Gene Therapy Tools and Reagents, by Product Type, Through 2030
Table 50 : Italian Market for Cell and Gene Therapy Tools and Reagents, by Application, Through 2030
Table 51 : Rest of Europe Market for Cell and Gene Therapy Tools and Reagents, by Product Type, Through 2030
Table 52 : Rest of Europe Market for Cell and Gene Therapy Tools and Reagents, by Application, Through 2030
Table 53 : Asia-Pacific Market for Cell and Gene Therapy Tools and Reagents, by Product Type, Through 2030
Table 54 : Asia-Pacific Market for Cell and Gene Therapy Tools and Reagents, by Application, Through 2030
Table 55 : Asia-Pacific Market for Cell and Gene Therapy Tools and Reagents, by End User, Through 2030
Table 56 : Asia-Pacific Market for Cell and Gene Therapy Tools and Reagents, by Country, Through 2030
Table 57 : Chinese Market for Cell and Gene Therapy Tools and Reagents, by Product Type, Through 2030
Table 58 : Chinese Market for Cell and Gene Therapy Tools and Reagents, by Application, Through 2030
Table 59 : Japanese Market for Cell and Gene Therapy Tools and Reagents, by Product Type, Through 2030
Table 60 : Japanese Market for Cell and Gene Therapy Tools and Reagents, by Application, Through 2030
Table 61 : Indian Market for Cell and Gene Therapy Tools and Reagents, by Product Type, Through 2030
Table 62 : Indian Market for Cell and Gene Therapy Tools and Reagents, by Application, Through 2030
Table 63 : South Korean Market for Cell and Gene Therapy Tools and Reagents, by Product Type, Through 2030
Table 64 : South Korean Market for Cell and Gene Therapy Tools and Reagents, by Application, Through 2030
Table 65 : Rest of Asia-Pacific Market for Cell and Gene Therapy Tools and Reagents, by Product Type, Through 2030
Table 66 : Rest of Asia-Pacific Market for Cell and Gene Therapy Tools and Reagents, by Application, Through 2030
Table 67 : RoW Market for Cell and Gene Therapy Tools and Reagents, by Product Type, Through 2030
Table 68 : RoW Market for Cell and Gene Therapy Tools and Reagents, by Application, Through 2030
Table 69 : RoW Market for Cell and Gene Therapy Tools and Reagents, by End User, Through 2030
Table 70 : RoW Market for Cell and Gene Therapy Tools and Reagents, by Sub-Region, Through 2030
Table 71 : Global Ranking of Companies: Cell and Gene Therapy Tools and Reagents Market, 2024
Table 72 : Agreements, Collaborations and Partnerships: Global Market for Cell and Gene Therapy Tools and Reagents, 2021 - 2025
Table 73 : Acquisitions: Global Market for Cell and Gene Therapy Tools and Reagents, 2022 - 2025
Table 74 : VC Investments and Expansion Activities: Global Market for Cell and Gene Therapy Tools and Reagents, 2022 - 2025
Table 75 : ESG: Environmental Overview
Table 76 : Key Social and Governance Issues in the Global Market for Cell and Gene Therapy Tools and Reagents
Table 77 : Information Sources Used for this Report
Table 78 : Abbreviations Used in this Report
Table 79 : Abcam Ltd.: Company Snapshot
Table 80 : Abcam Ltd.: Product Portfolio
Table 81 : Abcam Ltd.: News/Key Developments, 2022 - 2023
Table 82 : Adverum Biotechnologies Inc.: Company Snapshot
Table 83 : Adverum Biotechnologies Inc.: Financial Performance, FY 2023 and 2024
Table 84 : Adverum Biotechnologies Inc.: Product Portfolio
Table 85 : Adverum Biotechnologies Inc.: News/Key Developments, 2022 - 2025
Table 86 : Akron Biotech: Company Snapshot
Table 87 : Akron Biotech: Product Portfolio
Table 88 : Akron Biotech: News/Key Developments, 2022 - 2025
Table 89 : Bio-Rad Laboratories Inc.: Company Snapshot
Table 90 : Bio-Rad Laboratories Inc.: Financial Performance, FY 2023 and 2024
Table 91 : Bio-Rad Laboratories Inc.: Product Portfolio
Table 92 : Bio-Rad Laboratories Inc.: News/Key Developments, 2021 - 2025
Table 93 : Bio-Techne: Company Snapshot
Table 94 : Bio-Techne: Financial Performance, FY 2023 and 2024
Table 95 : Bio-Techne: Product Portfolio
Table 96 : Bio-Techne: News/Key Developments, 2022 - 2025
Table 97 : Cytiva: Company Snapshot
Table 98 : Cytiva: Product Portfolio
Table 99 : Cytiva: News/Key Developments, 2021 - 2024
Table 100 : FUJIFILM Irvine Scientific (FUJIFILM Biosciences): Company Snapshot
Table 101 : FUJIFILM Irvine Scientific (FUJIFILM Biosciences): Product Portfolio
Table 102 : FUJIFILM Irvine Scientific (FUJIFILM Biosciences) : News/Key Developments, 2022 - 2025
Table 103 : Merck KGaA: Company Snapshot
Table 104 : Merck KGaA: Financial Performance, FY 2023 and 2024
Table 105 : Merck KGaA: Product Portfolio
Table 106 : Merck KGaA: News/Key Developments, 2023 - 2025
Table 107 : Miltenyi Biotec: Company Snapshot
Table 108 : Miltenyi Biotec: Product Portfolio
Table 109 : Miltenyi Biotec: News/Key Developments, 2023 - 2024
Table 110 : Proteintech Group Inc.: Company Snapshot
Table 111 : Proteintech Group Inc.: Product Portfolio
Table 112 : Qiagen: Company Snapshot
Table 113 : Qiagen: Financial Performance, FY 2023 and 2024
Table 114 : Qiagen: Product Portfolio
Table 115 : Qiagen: News/Key Developments, 2023 - 2024
Table 116 : Revvity: Company Snapshot
Table 117 : Revvity: Financial Performance, FY 2023 and 2024
Table 118 : Revvity: Product Portfolio
Table 119 : Revvity: News/Key Developments, 2023 - 2025
Table 120 : Sartorius AG: Company Snapshot
Table 121 : Sartorius AG: Financial Performance, FY 2023 and 2024
Table 122 : Sartorius AG: Product Portfolio
Table 123 : Sartorius AG: News/Key Developments, 2023 - 2024
Table 124 : STEMCELL Technologies: Company Snapshot
Table 125 : STEMCELL Technologies: Product Portfolio
Table 126 : STEMCELL Technologies: News/Key Developments, 2022 - 2025
Table 127 : Thermo Fisher Scientific Inc.: Company Snapshot
Table 128 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2023 and 2024
Table 129 : Thermo Fisher Scientific Inc.: Product Portfolio
Table 130 : Thermo Fisher Scientific Inc.: News/Key Developments, 2022 - 2025
Table 131 : Emerging Startups in the Global Market for Cell and Gene Therapy Tools and Reagents